| Literature DB >> 21423727 |
Scott Cairns1, John Gilbert Thomas, Samuel James Hooper, Matthew Peter Wise, Paul John Frost, Melanie Julia Wilson, Michael Alexander Oxenham Lewis, David Wynne Williams.
Abstract
BACKGROUND: Ventilator-associated pneumonia is the most prevalent acquired infection of patients on intensive care units and is associated with considerable morbidity and mortality. Evidence suggests that an improved understanding of the composition of the biofilm communities that form on endotracheal tubes may result in the development of improved preventative strategies for ventilator-associated pneumonia. METHODOLOGY/PRINCIPALEntities:
Mesh:
Substances:
Year: 2011 PMID: 21423727 PMCID: PMC3056660 DOI: 10.1371/journal.pone.0014759
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Band numbers obtained by DGGE analysis, PCR and culture results for selected organisms.
| DGGE | PCR detection | Culture | |||||||
| Patient number | Endotracheal tube | Hours intubated | Number of bands |
|
|
|
|
| Total aerobic bacterial count cfu/cm2 endotracheal tube |
| 1 | 1 | 33 | 5 | 2.3×107 | |||||
| 2 | 2 | 108 | 16 | + | + | 6.3×106 | |||
| 2 | 7 | 94 | 4 | 2.8×107 | |||||
| 3 | 3 | 60 | 17 | + | 1.8×106 | ||||
| 4 | 4 | 95 | 14 | + | 6.1×106 | ||||
| 5 | 5 | 43 | 22 | + | 2.0×104 | ||||
| 6 | 10 | 41 | 9 | + | + | 0 | |||
| 7 | 8 | 289 | 8 | 3.0×107 | |||||
| 8 | 9 | 173 | 15 | + | + | + | + | 4.0×104 | |
| 9 | 11 | 198 | 10 | + | 2.1×108 | ||||
| 10 | 12 | 56 | 6 | + | 2.0×106 | ||||
| 11 | 13 | 137 | 5 | 7.7×106 | |||||
| 12 | 14 | 12 | 3 | 4.0×104 | |||||
| 12 | 15 | 20 | 5 | + | 0 | ||||
| 12 | 16 | 96 | 6 | + | + | 1.6×105 | |||
| 13 | 17 | 224 | 4 | 0 | |||||
| 14 | 18 | 49 | 5 | + | + | 0 | |||
| 15 | 19 | 29 | 3 | 4.0×104 | |||||
| 16 | 20 | 67 | 7 | + | + | 1.3×107 | |||
| 17 | 21 | 20 | 5 | + | 0 | ||||
| 17 | 24 | 143 | 5 | + | 7.7×106 | ||||
| 18 | 22 | 76 | 4 | + | + | 1.4×107 | |||
| 19 | 23 | 32 | 9 | + | + | 1.8×105 | |||
| 20 | 25 | 125 | 3 | 8.2×106 | |||||
Figure 1DGGE profiles of PCR amplified 16S rRNA from marker bacteria and endotracheal tube (ETT) biofilm samples.
1, P. gingivalis; 2, S. aureus; 3, S. mutans; 4, mixed marker of P. gingivalis, S. aureus and S. mutans; 5, ETT1; 6, ETT2; 7, ETT3; 8, ETT4; 9, ETT5; 10, ETT7; 11, ETT8; 12, ETT9; 13, ETT10; 14, ETT11; 15, mixed marker of P. gingivalis, S. aureus and S. mutans. 1, mixed marker of P. gingivalis, S. aureus and S. mutans; 2, ETT12; 3, ETT14; 4, ETT15; 5, ETT19; 6 ETT21; 7, ETT25; 8, ETT26; 9, mixed marker of P. gingivalis, S. aureus and S. mutans. 1, Plaque sample control; 2, mixed marker of P. gingivalis, S. aureus and S. mutans; 3, ETT13; 4, ETT16;5, ETT17; 6, ETT18; 7, ETT20; 8, ETT22; 9, ETT23; 10, ETT24; 11, mixed marker of P. gingivalis, S. aureus and S. mutans.
Figure 2Cluster analysis with Ward's algorithm based on the Dice coefficient demonstrating the diversity in DGGE profiles generated from endotracheal tube (ETT) biofilms.
Figure 3Result of the P. gingivalis-specific PCR using template DNA obtained from the biofilms recovered from endotracheal tubes 1 – 25.
Lane 26 contains the result from a dental plaque sample known to contain P. gingivalis, used here as a positive control. Lane 27 is a positive control using template DNA from P. gingivalis NCTC 11834T. Lane 28 is the template-free negative control.